Provided by Tiger Trade Technology Pte. Ltd.

TransMedics Group, Inc.

94.77
+3.924.31%
Post-market: 94.70-0.0700-0.07%19:55 EDT
Volume:628.72K
Turnover:59.14M
Market Cap:3.27B
PE:23.59
High:95.18
Open:91.11
Low:90.45
Close:90.85
52wk High:156.00
52wk Low:60.11
Shares:34.54M
Float Shares:33.28M
Volume Ratio:1.04
T/O Rate:1.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.02
EPS(LYR):4.87
ROE:36.28%
ROA:4.33%
PB:6.32
PE(LYR):19.46

Loading ...

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS Pathways (CMPS)

TIPRANKS
·
Aug 13

TransMedics Rilis Presentasi Soal Teknologi Perfusi Organ Portabel Dan Jaringan Layanan-Logistik Transplantasi Nasional

Reuters
·
Aug 12

TransMedics Group Price Target Cut to $100.00/Share from $120.00 by Piper Sandler

Dow Jones
·
Aug 06

UBS Adjusts Price Target on TransMedics Group to $77 From $80, Maintains Neutral Rating

MT Newswires Live
·
Aug 05

TransMedics price target lowered to $95 from $124 at Canaccord

TIPRANKS
·
Aug 05

Transmedics Group, Inc. : Canaccord Genuity Cuts Target Price to $95 from $124

THOMSON REUTERS
·
Aug 05

Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (IDYA) and TransMedics Group (TMDX)

TIPRANKS
·
Aug 05

Transmedics Group Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

TransMedics Q2 Net Income Declines on R&D and Infrastructure Expenses

Reuters
·
Aug 05

TransMedics Q2 FY26 GAAP Net Income Drops 58% to USD 14.7 Million; Revenue Rises 21% to USD 189.9 Million

Reuters
·
Aug 05

TransMedics Gr Q2 Adj. EPS $0.44 Misses $0.47 Estimate, Sales $189.948M Beat $183.635M Estimate

Benzinga Earnings
·
Aug 05

Transmedics Group Q2 EPS USD 0.41

Reuters
·
Aug 05

Transmedics Group Inc Fy2026 REV View $732.7 Mln

THOMSON REUTERS
·
Aug 05

TransMedics Grants 9 New Hires Stock Options for 18,762 Shares at $78, Awards 12,414 RSUs

Reuters
·
Aug 04

Transmedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 04

TransMedics Group Lawsuit Ruling: Court Allows Key Investor Claims Over Alleged Forced Bundling to Move Forward

TIPRANKS
·
Jul 30

Earning Preview: TransMedics Group, Inc. Q2 revenue is expected to increase by 24.01%, institutional views tilt bullish

Earnings Agent
·
Jul 29

TransMedics Group Initiated at Neutral by UBS

Dow Jones
·
Jul 29

UBS Initiates TransMedics Group at Neutral With $80 Price Target

MT Newswires Live
·
Jul 28

Transmedics Schedules Second-quarter Results Conference Call

Reuters
·
Jul 22